Cupid raises FY27 outlook after Q1 revenue jumps 159% to ₹155 crore
Cupid posted Q1 FY27 net profit of ₹44 crore, up from ₹15 crore a year earlier, as EBITDA rose 265% to ₹60 crore. The healthcare and FMCG company lifted FY27 revenue guidance to ₹725–750 crore and profit guidance to ₹210–225 crore, supported by export price hikes and domestic consumer growth.
What happened
Cupid reported strong Q1 FY27 growth across international B2B healthcare and domestic consumer healthcare/FMCG, aided by export price increases and favourable
Key facts
- Q1 FY27 consolidated net profit: ₹44 crore, versus ₹15 crore year-on-year
- Q1 FY27 revenue: ₹155 crore, up 159% YoY
- Q1 FY27 EBITDA: ₹60 crore, up 265% YoY
- EBITDA margin: 39%, up 1,127 basis points
- Export portfolio price increase: at least 10%
What changed
Cupid reported strong Q1 FY27 growth across international B2B healthcare and domestic consumer healthcare/FMCG, aided by export price increases and favourable USD/INR. It raised FY27 revenue guidance to ₹725-750 crore and net-profit guidance to ₹210-225 crore.
Why this matters
Cupid’s 159% Q1 revenue growth and higher FY27 outlook signal strong demand momentum, making export pricing execution and domestic FMCG scale-up the key operational priorities.
What to watch
- Q2 revenue growth versus the annualized pace required to achieve ₹725-750 crore FY27 revenue.
- Whether EBITDA margin remains near Q1 levels after advertising, distribution and expansion spending.
- Export volume response to price hikes, including order renewals, tender wins and customer concentration.
- Domestic FMCG repeat sales, new distribution reach and contribution from newer product categories.
- Receivables, inventory and operating cash flow, which may weaken if growth is driven by exports or channel stocking.
Also reported by
- Mint · Markets — 1h after first sighting